GlassScriptPhysician profile
Mohamad Lazkani
NPI 1174843403
$13,637.22
in general payments reported to CMS, 2019-2025
20 companies · $3,490 in 2025
The $3,490 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,754 · 2020: $578 · 2021: $409 · 2022: $537 · 2023: $833 · 2024: $1,037 · 2025: $3,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,810 · Travel and Lodging: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,809.98 |
| Travel and Lodging | $1,550.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $7,143.83 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,948.90 | 2019-2024 | Amplatzer Amulet, Amplatzer Talisman, Mitraclip |
| Boston Scientific Corporation | $1,240.03 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Medical Device Business Services, INC. | $1,163.62 | 2019 | |
| Medtronic, INC. | $915.26 | 2021-2025 | Corevalve Evolut R, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $300.60 | 2025 | Lifevest |
| Abiomed | $241.88 | 2024 | Impella |
| Shockwave Medical, INC | $160.12 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $123.32 | 2019 | |
| Cleerly, INC. | $97.80 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Merck Sharp & Dohme LLC | $51.98 | 2025 | Verquvo |
| Amgen INC. | $48.86 | 2025 | Repatha |
| W. L. Gore & Associates, INC. | $31.67 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $31.06 | 2025 | |
| Atricure, INC. | $30.20 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26.83 | 2025 | Flowtriever |
| Nipro Medical Corporation | $26.62 | 2025 | Hemodialysis System |
| Inspire Medical Systems, INC. | $23.17 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $17.44 | 2025 | |
| Kestra Medical Technology Services, INC. | $14.03 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamad Lazkani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.